Caspase-Independent Pathway of Amyloid-Beta Cytotoxicity

About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2003 - March 31, 2005
Grant ID
A2003223
Summary
Neuronal loss induced by oligomerized amyloid beta (Aß) peptide is an important feature of Alzheimer’s disease. It has been proposed that apoptotic cell death, the body’s own suicide program to ensure the elimination of dangerous cells, may contribute to the neuronal loss in AD. However, the inhibition of caspases, a family of proteases that execute apoptosis, only partially relieves the cytotoxicity induced by AD, which suggests that other, caspase-independent cell death pathways must exist. In previous work, Dr. Degterev defined a novel caspase-independent cell death pathway named “aponecrosis.” He identified two inhibitors (ANI1 and ANI2) that specifically inhibit aponecrosis in a number of cell types. The major goal of this study is to identify the molecular mechanism of the aponecrotic pathway induced by Aß in vitro and to define its role in animal models of AD. Ultimately, this work could lead to the identification of novel molecular targets for drug interventions in AD, and ANIs may serve as potential prototypes and/or target compounds in the development of new AD treatments.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD